Mello Marco Antonio Araújo de, Pereira-Rufino Laís da Silva, Santos Antonio Alceu Dos, Hossne Nelson Americo, Panfilio Carlos Eduardo, Souza Albert Schiaveto de, Céspedes Isabel Cristina
Instituto de Biociências, Universidade Federal do Mato Grosso do Sul - UFMS, Campo Grande, Mato Grosso do Sul, Brazil.
Department of Morphology and Genetics, Disciplina de Genética, Escola Paulista de Medicina, Universidade Federal de São Paulo - UNIFESP, São Paulo, São Paulo, Brazil.
Braz J Cardiovasc Surg. 2025 May 30;40(3):e20240244. doi: 10.21470/1678-9741-2024-0244.
Blood transfusion is associated with adverse clinical and surgical outcomes. Strategies like the Patient Blood Management program, which includes blood cell salvage, contribute to reducing the use of blood components. Blood cell salvage is very useful in heart surgeries where the patient's blood loss can be massive.
The present study aimed to evaluate the impact of using the blood cell salvage in the intraoperative and postoperative periods (up to 24 hours) on the hemoglobin and hematocrit values, transfusion of red blood cells, infection rates, and postoperative length of stay in patients undergoing cardiac surgery with cardiopulmonary bypass.
Forty-one patients who underwent cardiac surgery with cardiopulmonary bypass according to the inclusion criteria were selected in an observational study and separated into two groups: with the use of the blood cell salvage group (BCS, n = 21) and without the use of the blood cell salvage (WBCS, n = 20).
Patients in the group using blood cell salvage had higher postoperative hemoglobin (P = 0.018) and postoperative hematocrit levels (P = 0.009), lower consumption of red blood cells in the postoperative period and hospital discharge (P < 0.001), shorter postoperative length of stay (P = 0.020), and lower infection rates (P = 0.009).
Patient Blood Management strategies, particularly the use of blood cell salvage in the intraoperative and immediate postoperative periods of patients undergoing cardiac surgery with cardiopulmonary bypass, are associated with less use of blood components and consequently better clinical outcomes.
输血与不良的临床和手术结果相关。诸如患者血液管理计划（其中包括血细胞回收）等策略有助于减少血液成分的使用。血细胞回收在心脏手术中非常有用，因为此类手术中患者失血量可能很大。
本研究旨在评估在体外循环心脏手术患者的术中和术后（长达24小时）使用血细胞回收对血红蛋白和血细胞比容值、红细胞输注、感染率以及术后住院时间的影响。
在一项观察性研究中，根据纳入标准选择了41例行体外循环心脏手术的患者，并将其分为两组：使用血细胞回收组（BCS，n = 21）和未使用血细胞回收组（WBCS，n = 20）。
使用血细胞回收组的患者术后血红蛋白水平较高（P = 0.018），术后血细胞比容水平较高（P = 0.009），术后及出院时红细胞消耗量较低（P < 0.001），术后住院时间较短（P = 0.020），感染率较低（P = 0.009）。
患者血液管理策略，尤其是在体外循环心脏手术患者术中和术后立即使用血细胞回收，与较少使用血液成分相关，因此临床结果更好。
